Organisms | Evidence |
---|---|
Ovis aries (sheep) | |
Cricetulus griseus (Chinese hamster) | |
Mus musculus (house mouse) | |
Bos taurus (domestic cattle) | |
Escherichia coli |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
B3GNT6 | UDP-GlcNAc |
|
[alpha]-pNP |
|
[alpha]-pNP |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC4 | CMP-Neu5Ac |
|
benzyl |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[Ala-Thr(*)-Ala]2-7 |
|
[Ala-Thr(*)-Ala]2-7 |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
---|---|---|---|---|
ST6GALNAC3 | CMP-Neu5Ac |
|
Ser/Thr | |
ST6GAL2 | CMP-Neu5Ac |
|
para-nitrophenol | |
ST6GALNAC2 | CMP-Neu5Ac |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[alpha]-Bz | |
ST6GALNAC2 | CMP-Neu5Ac |
|
Ser/Thr |
UniProt ID | Protein Name | Reference | Source |
---|---|---|---|
O96005 | Putative lipid scramblase CLPTM1 | ||
P00450 | Ceruloplasmin | ||
P00734 | Prothrombin | ||
P00740 | Coagulation factor IX | ||
P00742 | Coagulation factor X | ||
P00747 | Plasminogen | ||
P00748 | Coagulation factor XII | ||
P00749 | Urokinase-type plasminogen activator | ||
P00750 | Tissue-type plasminogen activator | ||
P00751 | Complement factor B |
Pathway Name | Organism |
---|---|
E.coli O128ac | Escherichia coli |
E.coli O138 | Escherichia coli |
E.coli O142 | Escherichia coli |
E.coli O154 | Escherichia coli |
E.coli O157 | Escherichia coli |
E.coli O158ab | Escherichia coli |
E.coli O166 | Escherichia coli |
E.coli O176 | Escherichia coli |
E.coli O184 | Escherichia coli |
E.coli O185 | Escherichia coli |
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
27162272 | Blood Group O–Dependent Cellular Responses to Cholera Toxin: Parallel Clinical and Epidemiological Links to Severe Cholera | Kuhlmann FM | 2016 Aug 03 |
|
27268307 | Conjugation of mono and di-GalNAc sugars enhances the potency of antisense oligonucleotides via ASGR mediated delivery to hepatocytes | Kinberger GA | 2016 Aug 01 |
|
27121751 | 5′‐(E)‐Vinylphosphonate: A Stable Phosphate Mimic Can Improve the RNAi Activity of siRNA–GalNAc Conjugates | Parmar R | 2016 Apr 28 |
|
26951635 | Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk | Lawler PR | 2016 Apr 01 |
|
26881119 | Distribution of N-Acetylgalactosamine-Positive Perineuronal Nets in the Macaque Brain: Anatomy and Implications | Mueller AL | 2016 |
|
26472437 | Synthesis and Conjugation of Small Interfering Ribonucleic Neutral SiRNNs | Hamil AS | 2016 |
|
26247336 | The effect of water on the binding of glycosaminoglycan saccharides to hydroxyapatite surfaces: a molecular dynamics study | Ruiz Hernandez SE | 2015 Sep 14 |
|
26250751 | Substantial Receptor‐induced Structural Rearrangement of Rotavirus VP8*: Potential Implications for Cross‐Species Infection | Yu X | 2015 Sep 03 |
|
26299345 | Solid-phase synthesis of 5′-triantennary N-acetylgalactosamine conjugated antisense oligonucleotides using phosphoramidite chemistry | Prakash TP | 2015 Oct 01 |
|
26648038 | Structural studies on a non-toxic homologue of type II RIPs from bitter gourd: Molecular basis of non-toxicity, conformational selection and glycan structure | Chandran T | 2015 Nov 28 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025